742 related articles for article (PubMed ID: 29904241)
1. Microbial markers in colorectal cancer detection and/or prognosis.
Villéger R; Lopès A; Veziant J; Gagnière J; Barnich N; Billard E; Boucher D; Bonnet M
World J Gastroenterol; 2018 Jun; 24(22):2327-2347. PubMed ID: 29904241
[TBL] [Abstract][Full Text] [Related]
2. Faecal microbial biomarkers in early diagnosis of colorectal cancer.
Olovo CV; Huang X; Zheng X; Xu M
J Cell Mol Med; 2021 Dec; 25(23):10783-10797. PubMed ID: 34750964
[TBL] [Abstract][Full Text] [Related]
3. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM
J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
[TBL] [Abstract][Full Text] [Related]
5. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.
Kim M; Vogtmann E; Ahlquist DA; Devens ME; Kisiel JB; Taylor WR; White BA; Hale VL; Sung J; Chia N; Sinha R; Chen J
mBio; 2020 Feb; 11(1):. PubMed ID: 32071266
[TBL] [Abstract][Full Text] [Related]
6. Significance of the gut microbiome in multistep colorectal carcinogenesis.
Mizutani S; Yamada T; Yachida S
Cancer Sci; 2020 Mar; 111(3):766-773. PubMed ID: 31910311
[TBL] [Abstract][Full Text] [Related]
7. The Role of Fecal
Liu K; Yang X; Zeng M; Yuan Y; Sun J; He P; Sun J; Xie Q; Chang X; Zhang S; Chen X; Cai L; Xie Y; Jiao X
Dis Markers; 2021; 2021():1171239. PubMed ID: 34853619
[TBL] [Abstract][Full Text] [Related]
8. Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer.
Zhang S; Kong C; Yang Y; Cai S; Li X; Cai G; Ma Y
Theranostics; 2020; 10(25):11595-11606. PubMed ID: 33052235
[No Abstract] [Full Text] [Related]
9. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer.
Sánchez-Alcoholado L; Ordóñez R; Otero A; Plaza-Andrade I; Laborda-Illanes A; Medina JA; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947866
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fecal microbial markers in colorectal cancer detection.
Eklöf V; Löfgren-Burström A; Zingmark C; Edin S; Larsson P; Karling P; Alexeyev O; Rutegård J; Wikberg ML; Palmqvist R
Int J Cancer; 2017 Dec; 141(12):2528-2536. PubMed ID: 28833079
[TBL] [Abstract][Full Text] [Related]
11. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.
Yu J; Feng Q; Wong SH; Zhang D; Liang QY; Qin Y; Tang L; Zhao H; Stenvang J; Li Y; Wang X; Xu X; Chen N; Wu WK; Al-Aama J; Nielsen HJ; Kiilerich P; Jensen BA; Yau TO; Lan Z; Jia H; Li J; Xiao L; Lam TY; Ng SC; Cheng AS; Wong VW; Chan FK; Xu X; Yang H; Madsen L; Datz C; Tilg H; Wang J; Brünner N; Kristiansen K; Arumugam M; Sung JJ; Wang J
Gut; 2017 Jan; 66(1):70-78. PubMed ID: 26408641
[TBL] [Abstract][Full Text] [Related]
12. Altered intestinal microbiota associated with colorectal cancer.
Zhang H; Chang Y; Zheng Q; Zhang R; Hu C; Jia W
Front Med; 2019 Aug; 13(4):461-470. PubMed ID: 31250341
[TBL] [Abstract][Full Text] [Related]
13. First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screening.
Grobbee EJ; Lam SY; Fuhler GM; Blakaj B; Konstantinov SR; Bruno MJ; Peppelenbosch MP; Kuipers EJ; Spaander MC
United European Gastroenterol J; 2020 Apr; 8(3):293-302. PubMed ID: 32213018
[TBL] [Abstract][Full Text] [Related]
14. Reduction of faecal immunochemical test false-positive results using a signature based on faecal bacterial markers.
Malagón M; Ramió-Pujol S; Serrano M; Serra-Pagès M; Amoedo J; Oliver L; Bahí A; Mas-de-Xaxars T; Torrealba L; Gilabert P; Miquel-Cusachs JO; García-Nimo L; Saló J; Guardiola J; Piñol V; Cubiella J; Castells A; Aldeguer X; Garcia-Gil J
Aliment Pharmacol Ther; 2019 Jun; 49(11):1410-1420. PubMed ID: 31025420
[TBL] [Abstract][Full Text] [Related]
15. Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancer.
Löwenmark T; Löfgren-Burström A; Zingmark C; Eklöf V; Dahlberg M; Wai SN; Larsson P; Ljuslinder I; Edin S; Palmqvist R
Sci Rep; 2020 Sep; 10(1):15250. PubMed ID: 32943695
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of microbiome-derived biomarkers for early colorectal cancer detection.
Zwezerijnen-Jiwa FH; Sivov H; Paizs P; Zafeiropoulou K; Kinross J
Neoplasia; 2023 Feb; 36():100868. PubMed ID: 36566591
[TBL] [Abstract][Full Text] [Related]
17. Progress of gut microbiome and its metabolomics in early screening of colorectal cancer.
Zhou L; Jiang Z; Zhang Z; Xing J; Wang D; Tang D
Clin Transl Oncol; 2023 Jul; 25(7):1949-1962. PubMed ID: 36790675
[TBL] [Abstract][Full Text] [Related]
18. The Role of Fusobacterium nucleatum in Colorectal Carcinogenesis.
Datorre JG; de Carvalho AC; Guimarães DP; Reis RM
Pathobiology; 2021; 88(2):127-140. PubMed ID: 33291114
[TBL] [Abstract][Full Text] [Related]
19. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer.
Avuthu N; Guda C
Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483
[TBL] [Abstract][Full Text] [Related]
20. BRAF
Trivieri N; Pracella R; Cariglia MG; Panebianco C; Parrella P; Visioli A; Giani F; Soriano AA; Barile C; Canistro G; Latiano TP; Dimitri L; Bazzocchi F; Cassano D; Vescovi AL; Pazienza V; Binda E
J Exp Clin Cancer Res; 2020 Dec; 39(1):285. PubMed ID: 33317591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
